NKTR
$39.22+7.04%
Nektar TherapeuticsStock · HealthcareRussell 2000 · 0.08% of IWMNasdaq Composite · 0.004% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.003% of IWV
NKTR financial statements
The full income statement, balance sheet, and cash-flow statement for Nektar Therapeutics (NKTR), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2025-06 19.0M2025-09 20.3M2025-12 28.7M2026-03 20.4M2026-06 34.1M+79.5% over 4 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Revenue | 55.2M-43.9% | 98.4M+9.2% | 90.1M-2.1% | 92.1M-9.7% | 102M-33.4% | |
| Cost of revenue | 0.00-100.0% | 30.7M-9.1% | 33.8M+56.1% | 21.6M-13.1% | 24.9M+27.8% | |
| Research & development | 117M-3.0% | 121M+5.9% | 114M-47.7% | 218M-45.5% | 400M-2.1% | |
| Selling, general & administrative | 68.7M-10.5% | 76.8M-0.9% | 77.4M-16.2% | 92.3M-24.8% | 123M+17.3% | |
| General & administrative | 68.7M-10.5% | 76.8M-0.9% | 77.4M-16.2% | 92.3M-24.8% | 123M+17.3% | |
| Provision for credit losses | 0.00 | 0.00 | 0.00 | — | — | |
| Operating income | -140M-33.2% | -105M+60.1% | -264M+29.9% | -376M+15.7% | -446M-4.9% | |
| Interest expense | — | — | — | 0.00 | 0.00-100.0% | |
| Interest & investment income | 10.4M-28.0% | 14.5M-23.7% | 19.0M+180.2% | 6.78M+148.4% | 2.73M | |
| Other non-operating income | 361K+192.6% | -390K+93.8% | -6.25M-5285.3% | -116K+28.4% | -162K-100.9% | |
| Equity-method income | -8.73M | 0.00 | — | — | — | |
| Pre-tax income | -164M-37.8% | -119M+56.9% | -276M+24.3% | -365M+30.3% | -523M-17.9% | |
| Income tax | -138K+42.3% | -239K-19.5% | -200K-106.2% | 3.21M+477.2% | 557K+13.0% | |
| Net income | -164M-37.9% | -119M+56.9% | -276M+25.0% | -368M+29.7% | -524M-17.9% | |
| -$9.73-12.1% | -$8.68+60.1% | -$21.75+26.4% | -$29.55+31.1% | -$42.90-14.9% | ||
| EPS (basic) | -$9.73-12.1% | -$8.68+60.1% | -$21.75+26.4% | -$29.55+31.1% | -$42.90-14.9% | |
| Weighted-avg shares (basic) | 16.9M+23.0% | 13.7M+8.2% | 12.7M+1.5% | 12.5M+2.1% | 12.2M+2.6% | |
| Weighted-avg shares (diluted) | 16.9M+23.0% | 13.7M+8.2% | 12.7M+1.5% | 12.5M+2.1% | 12.2M+2.6% | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 266M+1.9% | 261M-21.0% | 331M-39.4% | 546M-31.4% | 796M-30.1% | ||
| Cash & equivalents | 15.1M-65.8% | 44.3M+25.4% | 35.3M-60.0% | 88.2M+249.9% | 25.2M-87.3% | |
| Accounts receivable | — | 0.00-100.0% | 1.21M-79.9% | 5.98M-73.4% | 22.5M-42.2% | |
| Inventory | 0.00 | 0.00-100.0% | 16.1M-16.1% | 19.2M+21.5% | 15.8M+3.3% | |
| Other current assets | 20.5M+238.2% | 6.07M-38.0% | 9.78M-38.1% | 15.8M-32.3% | 23.3M+6.4% | |
| 280M-7.7% | 304M-23.7% | 398M-44.0% | 711M-36.4% | 1.12B-27.4% | ||
| Property, plant & equipment | 2.06M-39.6% | 3.41M-81.9% | 18.9M-41.9% | 32.5M-46.4% | 60.5M+1.4% | |
| Operating lease right-of-use | 2.94M-65.0% | 8.41M-53.3% | 18.0M-66.3% | 53.4M-54.3% | 117M-7.5% | |
| Goodwill | — | — | 0.00-100.0% | 76.5M+0.0% | 76.5M+0.0% | |
| Other non-current assets | 14.1M+204.3% | 4.65M+0.1% | 4.64M+106.9% | 2.25M-18.2% | 2.74M+87.8% | |
| 53.5M-12.8% | 61.4M+19.8% | 51.3M-24.8% | 68.2M-19.9% | 85.2M-26.4% | ||
| Accounts payable | 10.8M-6.8% | 11.6M+17.4% | 9.85M-24.1% | 13.0M+33.2% | 9.75M-56.0% | |
| Accrued liabilities | 22.3M-25.7% | 30.0M+35.2% | 22.2M-39.4% | 36.6M | — | |
| Current lease liability | 20.5M+3.2% | 19.9M+3.2% | 19.3M+3.2% | 18.7M+7.0% | 17.4M+25.3% | |
| 191M-21.6% | 243M-9.0% | 267M-22.4% | 344M-21.4% | 438M-5.2% | ||
| Non-current lease liability | 65.3M-21.1% | 82.7M-16.1% | 98.5M-12.7% | 113M-10.3% | 126M-7.8% | |
| Operating lease liability (total) | 85.8M-16.4% | 103M-12.9% | 118M-10.4% | 131M-8.2% | 143M-4.7% | |
| Other non-current liabilities | 8.63M+19.1% | 7.24M+56.2% | 4.63M-38.6% | 7.55M+110.2% | 3.59M-60.0% | |
| 89.8M+47.9% | 60.7M-53.6% | 131M-64.3% | 367M-46.0% | 680M-36.9% | ||
| Preferred stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock | 2.00K+100.0% | 1.00K-94.7% | 19.0K+0.0% | 19.0K+0.0% | 19.0K+5.6% | |
| Additional paid-in capital | 3.85B+5.2% | 3.66B+1.4% | 3.61B+0.9% | 3.57B+1.7% | 3.52B+3.8% | |
| Retained earnings | -3.76B-4.6% | -3.60B-3.4% | -3.48B-8.6% | -3.20B-13.0% | -2.83B-22.7% | |
| Treasury stock | — | 3.00M | 0.00 | — | — | |
| Accumulated other comprehensive income | 17.0K-72.1% | 61.0K-23.8% | 80.0K+101.2% | -6.91M-66.2% | -4.16M-81.1% | |
| Total liabilities & equity | 280M-7.7% | 304M-23.7% | 398M-44.0% | 711M-36.4% | 1.12B-27.4% | |
| Common shares issued | 34.1M+163.8% | 12.9M+1.4% | 12.8M+1.5% | 12.6M+1.7% | 12.4M+3.0% | |
| Common shares outstanding | 20.4M+64.5% | 12.4M-2.9% | 12.8M+1.5% | 12.6M+1.7% | 12.4M+3.0% | |
| Shares outstanding (cover) | 28.7M+131.2% | 12.4M+1.4% | 12.2M-3.0% | 12.6M+1.6% | 12.4M+2.2% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -209M-18.7% | -176M+8.8% | -193M+36.6% | -304M+26.3% | -413M-31.7% | ||
| Depreciation & amortization | 1.03M-75.0% | 4.10M-41.4% | 7.00M-42.6% | 12.2M-6.2% | 13.0M+4.0% | |
| Deferred income taxes | 64.0K+740.0% | -10.0K+92.9% | -140K-105.2% | 2.71M+2754.9% | -102K-183.3% | |
| Change in receivables | 0.00-100.0% | 3.04M+163.8% | -4.78M+71.1% | -16.5M-33.2% | -12.4M-548.0% | |
| Change in inventory | 0.00+100.0% | -497K+28.9% | -699K-120.6% | 3.40M+568.2% | 509K-80.6% | |
| Change in payables | -625K-123.4% | 2.67M+192.5% | -2.88M-192.9% | 3.10M+126.5% | -11.7M-590.8% | |
| -1.20M-100.8% | 143M+2.2% | 140M-61.9% | 366M+80.4% | 203M-59.1% | ||
| Capital expenditure | 171K-88.4% | 1.47M+69.7% | 865K-84.8% | 5.68M-62.1% | 15.0M+106.5% | |
| Free cash flow | -209M-17.8% | -177M+8.4% | -193M+37.5% | -310M+27.6% | -428M-33.4% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales/maturities of investments | 285M-16.4% | 340M-47.7% | 651M-21.2% | 826M-29.2% | 1.17B-19.5% | |
| Proceeds from sale of PP&E | — | 0.00-100.0% | 1.25M-90.6% | 13.2M | 0.00 | |
| 181M+328.7% | 42.1M+140293.3% | 30.0K-98.0% | 1.51M-95.8% | 36.2M+145.1% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00-100.0% | 3.00M | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| FX effect on cash | 6.00K+250.0% | -4.00K-106.5% | 62.0K+119.0% | -327K-255.4% | -92.0K-560.0% | |
| Net change in cash | -29.1M-424.6% | 8.97M+116.9% | -53.0M-184.0% | 63.0M+136.3% | -174M-269.3% | |
| Interest paid | — | — | — | 0.00 | 0.00-100.0% | |
| Income taxes paid | -195K-356.6% | 76.0K-97.1% | 2.66M+876.5% | 272K-16.3% | 325K-39.7% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.21B | — | — | — | — | |
| P/S | 22.0× | — | — | — | — | |
| P/B | 13.5× | — | — | — | — | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: NKTR’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all NKTR filings on SEC EDGAR → Not investment advice.